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a b s t r a c t
Elephant endotheliotropic herpesvirus 1 (EEHV1), a member of the Betaherpesvirinae subfamily, has
recently emerged as an important viral pathogen of Asian elephants that can cause a severe, often fatal,
hemorrhagic disease. EEHV1 does not replicate in culture and little is currently known about the
molecular biology of this emerging pathogen, with the notable exception of its genomic DNA sequence.
Here, we have used small RNA deep sequencing to determine whether EEHV1, like other human and
murine betaherpesviruses, expresses viral microRNAs in infected tissues in vivo. Our data provide
evidence supporting the existence of at least three novel viral microRNAs encoded by EEHV1 and one of
these, miR-E3-5p, is shown to repress target mRNA expression. Moreover, miR-E3-5p expression was
readily detectable in tissue samples derived from two infected elephants, including in whole blood. These
data shed new light on the biology of EEHV1 and identify small RNAs that have the potential to be useful
in the diagnosis of sub-clinical infections in captive Asian and African elephants.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Elephant endotheliotropic herpesvirus (EEHV) can cause
a severe hemorrhagic disease in Asian elephants (Elephas maximus)
(Richman et al., 1999). This disease, which is now believed to be
endemic in Asian elephants (Zachariah et al., 2013), has resulted in
a mortality rate of 80% among the approximately 80 known
infections over the last 20 years, and is especially serious in younger
animals (Hayward, 2012). EEHV1 is now recognized as a threat to
the continued survival of the endangered Asian elephant and EEHV1
is a particular problem among captive animals. The virus species
involved in most cases of fatal disease is elephant endotheliotropic
herpesvirus 1 (EEHV1), which exists as two genotypes, EEHV1A and
EEHV1B (Fickel et al., 2001). EEHV1 is classiﬁed as a member of the
Betaherpesvirinae subfamily (Pellett et al., 2011), members of which
also include viruses in the genera Cytomegalovirus (e.g., human
cytomegalovirus; HCMV) and Roseolovirus (e.g., human herpesvirus
7: HHV7). EEHV1 is somewhat more closely related to the Roseolo-
virus family, but is grouped as the separate genus Proboscivirus
(Wilkie et al., 2013). Importantly, it has not yet proven possible
to grow EEHV1 in culture, so relatively little is known about the
molecular biology of EEHV1, with the important exception that the
genomic DNA sequence of both EEHV1A and EEHV1B has been
reported (Wilkie et al., 2013).
MicroRNAs (miRNAs) are a large family of 22 nucleotide (nt)
regulatory RNAs that function to post-transcriptionally down-
regulate the expression of target mRNAs (reviewed in Bartel,
2009). They are typically transcribed as part of one arm of an
80-nt RNA stem-loop located within a longer capped, polyade-
nylated transcript, referred to as a primary miRNA (pri-miRNA)
(Cullen, 2004). This stem-loop is recognized by the RNase III
enzyme Drosha, which cleaves 22 bp away from the terminal
loop to generate an 60-nt RNA hairpin, bearing an 2-nt 30
overhang, referred to as the pre-miRNA intermediate. The pre-
miRNA is exported to the cytoplasmwhere it is recognized by Dicer,
a second RNase III enzyme which cleaves the pre-miRNA 22 bp
from the base of the pre-miRNA, leaving a second 2-nt 30
overhang, to generate a short RNA duplex. One strand of this duplex
is incorporated into the RNA-induced silencing complex (RISC) as a
mature miRNA while the second, passenger strand is degraded. The
mature miRNA then guides RISC to complementary target sites
located predominantly in the 30UTR of target mRNAs, resulting in
their translational repression and/or mRNA degradation (Bartel,
2009). While the choice of which strand of the miRNA duplex is
incorporated into RISC usually strongly favors one strand over the
other, this discrimination is rarely absolute and recovery of not only
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the miRNA strand but also the passenger strand is often a hallmark
of an authentic miRNA.
Many herpesviruses, including members of the Betaherpesvirinae,
are known to encode viral miRNAs (Buck et al., 2007; Cullen, 2009;
Dolken et al., 2007; Grey et al., 2005; Pfeffer et al., 2005; Tuddenham
et al., 2012). Yet, the existence of miRNAs encoded by EEHV1 has not
been previously addressed. Here, we examine the expression and
function of several candidate miRNAs expressed by EEHV1A in vivo.
Results
Deep sequencing of small RNAs from cardiac tissue derived
post-mortem from an EEHV1A-infected elephant (Raman) yielded
15,762,214 reads. Of these, 15,424,380 reads (97.9%) mapped to the
elephant genome and 6513 (0.04%) reads mapped to the EEHV1A
genome. As expected from an in vivo sample, the proportion of
reads that mapped to the viral genome was quite low. This likely
results from the fact that only a small percentage of the cells
recovered by tissue necropsy was actually infected with EEHV1, as
also observed previously by deep sequencing of in vivo samples
obtained post-mortem from HSV-1 or HSV-2 infected patients
(Umbach et al., 2009; Umbach et al., 2010).
A key characteristic of authentic miRNAs is that their size
clusters at 22 nt (Bartel, 2009) and indeed reads that mapped to
the elephant genome revealed a peak size of 22 nt in length
(Fig. 1A). Although little is currently known about elephant
miRNAs, we could readily identify several elephant miRNAs that
are conserved across vertebrate species, including humans. The 20
most frequently recovered elephant miRNAs are listed in
Supplementary Table 1. The most abundantly expressed elephant
miRNA was miR-486, which is known to be enriched in muscle
tissue (Small et al., 2010). This is as expected, as the tissues
analyzed were of cardiac origin. Importantly, reads that mapped
to the EEHV1 genome also showed a pronounced peak at 22 nt,
consistent with the hypothesis that EEHV1 encodes authentic viral
miRNAs (Fig. 1A). Many of these small RNAs (3053, 47% of the
total) were derived from 5 discrete locations within the EEHV1A
genome, here termed E1 through E5 (Fig. 1B), while the remainder
were scattered across the EEHV1A genome, as expected for viral
mRNA degradation products. The ﬁnding that many of these small
RNA reads derive from ﬁve discrete locations in the viral genome
again suggests that these represent authentic viral miRNAs.
Of note, the sequence of these ﬁve candidate miRNAs and their
immediate ﬂanking regions is fully conserved between EEHV1A
and EEHV1B (Wilkie et al., 2013). As for the other known subtypes
of EEHV, i.e., EEHV2, EEHV3, EEHV4, EEHV5 and EEHV6, the
currently available sequence data is not adequate to determine
whether these candidate miRNAs are also conserved in these virus
species.
A further characteristic of authentic viral miRNAs is that they
generally have a discrete 50 end, due to the importance of the
miRNA seed sequence (nt 2 through 8) in target mRNA recogni-
tion, while the 30 end is more variable (Bartel, 2009). As shown in
Table 1, which lists all potential EEHV1-derived miRNA and miRNA
passenger strand reads, the ﬁve putative EEHV1-derived mature
miRNAs E1-3p, E2-3p, E3-5p, E4-5p and E5-3p all exhibit an
invariant 50 end (E1 and E4), or two possible 50 ends (E2, E3
and E5), while there was considerable 30 end variation. In contrast,
small mRNA degradation products usually exhibit a range of
different 50 and 30 ends (Whisnant et al., 2013). This result is again
consistent with the idea that some or all of these small RNAs are
authentic EEHV1 miRNAs.
To further conﬁrm the existence of these small EEHV1-derived
RNAs, we also analyzed small RNAs isolated from an EEHV1-
infected necropsy sample of the liver of a second Asian elephant
(Nayan) that succumbed to an EEHV1A infection at the same zoo.
We extracted RNA from the liver tissue and conducted deep-
sequencing of small RNAs, resulting in 21.9 million reads that
could be mapped to either the elephant or EEHV1 genome. We
again detected small RNAs that mapped to the same ﬁve read
clusters E1 to E5 identiﬁed in the sample obtained from Raman,
the other elephant analyzed. These reads are listed in Table 1.
Of note, while the pattern of small RNAs obtained from were quite
similar in both samples, we did note that the dominant isoform of
miR-E1-3p, miR-E4-5p and miR-E5-3p recovered from the Nayan
sample all differed by 1 nt from that seen in the Raman sample
(Table 1). In contrast, the dominant isoform of miR-E3-5p was
identical in both samples.
As noted above, miRNAs form part of one arm of a stem-loop
and deep sequencing often recovers not only the mature miRNA
but also a passenger strand that is offset in the stem by 2 nt (e.g.,
Umbach and Cullen, 2010). In Fig. 2, we show computationally
predicted RNA secondary structures adopted by four of these ﬁve
small RNAs along with their viral ﬂanking sequences. The ﬁfth
small RNA, E4, appeared incapable of forming such a structure.
Moreover, the E4 reads were mostly shorter than the canonical
19–25nt size range for authentic miRNAs (Table 1) and E4 is
therefore likely not an authentic miRNA. In contrast, the other
candidate EEHV1 miRNAs did yield potential stem-loop structures
and, at least for E1, E2 and E3, these RNA structures are of the
approximately correct size and shape (Han et al., 2006; Zeng et al.,
2005). Moreover, for E1, E2 and E3 we recovered not only a
potential mature viral miRNA species but also possible passenger
strands that are indeed derived from the other arm of the stem
and offset by 2 nt (Fig. 2). In contrast, the reads obtained for
miR-E5 were overlapping on the predicted pre-miRNA stem,
which is not expected for an authentic pre-miRNA (Han et al.,
2006; Zeng et al., 2005).
Next, we cloned segments of the EEHV1A genome encompassing
each putative EEHV1A pri-miRNA sequence (the mature miRNA
along with 240 bp of 50 and 30 ﬂanking sequence; i.e. 500 bp of
viral DNA) into an expression vector, transfected them into human
293T cells and then used Northern blot analysis to test for mature
miRNA expression (Gottwein et al., 2006). This experiment showed
that pri-miR-E3 is efﬁciently processed into an 60-nt pre-miRNA
and an 22-nt mature miRNA in these transfected human cells
(Fig. 3). In contrast, we detected neither pre-miRNA nor mature
Fig. 1. Results of deep-sequencing. (A) Length distribution of reads that map to the
elephant or EEHV1A genome. (B) Site-by-site coverage (read counts at each site) of
the EEHV1A genome by deep-sequencing. The X-axis shows read positions from
the 50 end to the 30 end of the EEHV1A genome (GenBank; KC462165). Five
prominent sites of read origin (E1 through E5) were subjected to further analyses
and are designated by an arrow.
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miRNA production for the other four candidate EEHV1 pri-miRNAs
(data not shown).
We next asked if we could obtain evidence that these putative
EEHV1 miRNAs are biologically active. For this purpose, we
generated indicator vectors in which two fully complimentary
target sites for each of the ﬁve candidate EEHV1 miRNAs was
inserted into the 30UTR of a Renilla luciferase (RLuc) reporter gene
(Gottwein et al., 2006). We then transfected the human 293T cell
line with each miRNA expression vector and each viral miRNA
indicator construct and measured expression of RLuc and of the
ﬁreﬂy luciferase (FLuc) internal control. Co-transfection of any of
the putative EEHV1 miRNA expression vectors had no effect on
RLuc activity when no target sites had been inserted into the
30 UTR. In contrast, co-transfection of the miR-E3 expression vector
reduced luciferase activity dramatically when cognate target
sequences were cloned into 30 UTR of RLuc (Fig. 4). However, none
of the other four putative EEHV1 miRNA expression vectors,
encompassing E1, E2, E4 or E5 (Fig. 2), showed any activity. This
negative result is consistent with our inability to detect mature
miRNA expression by Northern blot of total RNA derived from
293T cells transfected with these same vectors.
Because many EEHV1 infections, especially in African
elephants, appear to be asymptomatic, there has been consider-
able interest in developing diagnostic reagents to detect EEHV1 in
Table 1
List of putative EEHV1A miRNAs.
Spot Origin Arm Sequence Length (nt) Positiona Read count
Beginning End Raman 15.4Mb Nayan 21.9Mb
E1 Non coding region 5p AAUUGCCUGCAGUGUUCACAGUA 23 6490 6468 1 0
UGCCUGCAGUGUUCACAGUAGC 22 6487 6466 1 0
3p UACUGAGAACACUGCAUCCC 20 6453 6434 134 37
UACUGAGAACACUGCAUCCCA 21 6453 6433 388 218
UACUGAGAACACUGCAUCCCAA 22 6453 6432 405 120
UACUGAGAACACUGCAUCCCAAU 23 6453 6431 381 139
E2 ORFc (U60) 5p ACAGGCAGCGUCUGUUAAGAU 21 42515 42535 0 1
ACAGGCAGCGUCUGUUAAGAUAG 23 42515 42537 0 1
ACAGGCAGCGUCUGUUAAGAUAGC 24 42515 42538 3 0
3p UCACUUAUCAGACUCUGCCU 20 42554 42573 7 0
UCACUUAUCAGACUCUGCCUGU 22 42554 42575 7 2
UCACUUAUCAGACUCUGCCUGUA 23 42554 42576 3 5
UCACUUAUCAGACUCUGCCUGUAU 24 42554 42577 168 15
CACUUAUCAGACUCUGCCUGUAU 23 42555 42577 193 22
CACUUAUCAGACUCUGCCUGUAUC 24 42555 42578 2 15
E3 Antisense of ORF (U42) 5p AACGGCGCUACUGUUGACUCGC 22 99533 99554 278 173
AACGGCGCUACUGUUGACUCGCU 23 99533 99555 106 39
ACGGCGCUACUGUUGACUCGC 21 99534 99554 5 6
ACGGCGCUACUGUUGACUCGCU 22 99534 99555 61 34
3p AAGAUUUAACGGUAGCGCCAUU 22 99567 99588 5 1
AAGAUUUAACGGUAGCGCCAUUC 23 99567 99589 1 0
AGAUUUAACGGUAGCGCCAUU 21 99568 99588 1 0
AGAUUUAACGGUAGCGCCAUUC 22 99568 99589 8 2
E4 Antisense of ORF (EE46) 5p CUUGAUCAUGAUGGUC 16 161228 161213 0 110
CUUGAUCAUGAUGGUCU 17 161228 161212 57 7
CUUGAUCAUGAUGGUCUU 18 161228 161211 51 2
CUUGAUCAUGAUGGUCUUU 19 161228 161210 35 1
3p Not detected
E5 ORF (EE63) 5p CACAGUCAAUGGUAUCGAGCC 21 177047 177027 0 21
AGUCAAUGGUAUCGAGCC 18 177044 177027 6 2
AGUCAAUGGUAUCGAGCCUCUCA 23 177044 177022 10 2
GUCAAUGGUAUCGAGCC 17 177043 177027 5 0
AAUGGUAUCGAGCCUCUCACAAGC 24 177040 177017 8 37
AAUGGUAUCGAGCCUCUCACAAGCU 25 177040 177016 21 192
3p CACAAGCUCGAUACCAUUGA 20 177023 177004 59 21
CACAAGCUCGAUACCAUUGAC 21 177023 177003 282 315
CACAAGCUCGAUACCAUUGACU 22 177023 177002 384 154
ACAAGCUCGAUACCAUUGAC 20 177022 177003 44 72
ACAAGCUCGAUACCAUUGACU 21 177022 177002 40 28
The most abundant miRNA read for Raman at each viral genomic location is bolded.
a 50 and 30 end positions refer to the genomic sequence of EEHV1A (Genbank; KC462165).
b Number of total reads mapped to either the elephant or EEHV1A genome. M; million.
c ORF; open reading frame.
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infected animals (Hardman et al., 2012; Sariya et al., 2012; Stanton
et al., 2010). MiRNAs, including viral miRNAs, are often expressed at
very high levels, are released into the serum and can be readily
detected using RT-PCR assays (Kuwabara et al., 2011; Tanaka et al.,
2013; Turchinovich et al., 2011; Tzimagiorgis et al., 2011) and we
therefore wondered if miR-E3-5p could be detected in vivo by RT-PCR.
We have access to a range of tissue samples derived from both
deceased Asian elephants, Raman and Nayan, as well as tissue derived
post-natally from an uninfected animal and we therefore designed a
TaqMan probe speciﬁc for miR-E3-5p and tested whether we could
indeed detect this viral miRNA in these in vivo samples.
For this purpose, we isolated total RNA from these tissue
samples, including whole blood, and then measured miR-E3-5p
expression by quantitative RT-qPCR (Table 2). As may be observed,
we failed to detect any miR-E3-5p expression in the negative
control tissue or in a tongue tissue sample derived from Raman,
but otherwise we were able to detect miR-E3-5p expression in all
samples analyzed, including most importantly whole blood. Parti-
cularly high levels of miR-E3-5p were detected in the heart and
liver of both animals (Table 2). We therefore conclude that miR-
E3-5p has the potential to serve as a biomarker for detection of
subclinical EEHV1 infections.
Discussion
A number of herpesviruses, including several human and non-
human Betaherpesviruses, have been shown to express viral miRNAs
in infected cells in culture or in vivo (Cullen, 2011; Grundhoff and
Sullivan, 2011). Here we have asked whether EEHV1, a pathogenic
Betaherpesvirus that causes a severe hemorrhagic disease in Asian
elephants, also has the potential to express viral miRNAs. Our initial
datawere very encouraging, as deep sequencing of small RNAs derived
from cardiac or liver tissue obtained from two Asian elephants that
had died from natural EEHV1A infections revealed several thousand
reads of EEHV1A origin that were tightly clustered around the
predicted 22 nt size for authentic viral miRNAs (Fig. 1A). Moreover,
many of these reads derived from ﬁve discrete locations in the EEHV1
genome (Fig. 1B), again as predicted for authentic viral miRNAs.
Analysis of the sequence of these small viral RNAs showed that they
displayed deﬁned 50 ends and also revealed several possible miRNA
passenger strands (Table 1). However, attempts to fold these miRNA,
along with its ﬂanking sequences, into the expected hairpin structure
was only successful in the case of candidate miRNAs E1, E2 and E3
(Fig. 2), with E4 lacking the ability to fold into any form of stable RNA
structure while E5 could only give rise to a stem-loop that was too
short to be an authentic pri-miRNA stem-loop (Han et al., 2006; Zeng
et al., 2005). Nevertheless, it was striking that E1, E2 and E3 not only
folded into a believable RNA structure with the candidate mature
miRNA located, as expected, immediately adjacent to the terminal loop
but also with the putative miRNA passenger strands offset on the
opposite side of the stem by 2 nt (Han et al., 2006; Zeng et al., 2005).
These ﬁndings led us to believe that E1, E2 and E3 are indeed
authentic EEHV1 miRNAs.
We next attempted to further validate this hypothesis by
generating expression vectors for all ﬁve candidate EEHV1 miRNAs,
E1 through E5, and asking if these could indeed give rise to
functional mature miRNAs as determined by Northern blot analysis
Fig. 2. Secondary structure of putative pri-miRNAs. Schematic stem-loop RNA structures predicted for the putative EEHV1A pri-miRNAs E1, E2, E3 and E5 are shown. The
bold line indicates the putative mature miRNA and the thin line indicates its possible passenger strand, based on deep sequencing (Table 1).
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and indicator assays using transfected human 293T cells. In the case
of EEHV1 miR-E3, we were able to both detect mature miR-E3, as
well as pre-miR-E3, by Northern blot (Fig. 3) and we were also able
to readily detect miR-E3 function by indicator assay (Fig. 4). In
contrast, the other four candidate EEHV1 miRNAs, E1, E2, E4 and E5,
were neither expressed as a mature miRNA nor functional in the
indicator assay.
The results presented in this manuscript identify miR-E3-5p as
the ﬁrst authentic EEHV1 miRNA. It is possible that all four of the
other candidate EEHV1 miRNAs are simply some form of stable
mRNA breakdown product and indeed that seems likely for E4,
which gives rise to reads that are mostly too short to be miRNAs,
fails to fold into an appropriate stem-loop structure and lacks a
potential passenger strand (Table 1). Similarly, the only stem-loop
we can derive for E5 is too small to form in a functional pri- or
even pre-miRNA (Fig. 2) and the potential passenger strands
overlap with E5 in this structure. So, while E4 and E5 are likely
not viral miRNAs, we remain persuaded that miR-E1 and miR-E2
are real. In particular, the reads obtained for miR-E1 and miR-E2
are all in the 20–24 nt size window (Table 1) and the predicted
structures adopted by these putative miRNAs are the right size and
reveal passenger strands offset by the predicted 2 nt on the
opposite arm of the stem (Fig. 2) (Han et al., 2006; Zeng et al.,
2005). This is very unlikely to occur by chance. The question then
is why these miRNAs do not express in transfected 293T cells.
In fact, while most viral miRNAs will express when inserted, along
with their native ﬂanking sequences, into an expression vector,
others fail to do so, including several miRNAs encoded by HSV-1
and a small number of the miRNAs encoded by KSHV or EBV (data
not shown). Why this is the case is unclear, but it appears possible
that they fail to fold appropriately when inserted into a hetero-
logous RNA sequence context. In any event, we have clearly shown
that EEHV1 expresses at least one functional miRNA, miR-E3-5p,
and we have presented evidence that we believe argues for at least
two others, here called miR-E1-3p and miR-E2-3p.
As EEHV1 miR-E3-5p is derived from the antisense strand of
a viral U42 ORF (Table 1), this miRNA could certainly post-
transcriptionally regulate the expression of this viral gene, as
previously reported for HSV-1 and EBV-encoded miRNAs (Barth
et al., 2008; Flores et al., 2013; Pfeffer et al., 2004; Umbach et al.,
2008). It is also possible that this viral miRNA regulates host mRNA
expression, as seen with several other herpesviruses (Cullen, 2009;
Grundhoff and Sullivan, 2011). We could not ﬁnd any homology of
the seed sequence of EEHV1 miR-E3-5p to that of other miRNAs
expressed by other betaherpesviruses, such as HCMV or HHV-6B.
However, it does share a partial seed sequence (positions 2 to 7;
ACGGCG) with a murine miRNA, mmu-miR-6241. Although the
miRNAs expressed by elephants have not yet been studied
extensively, it is possible that this EEHV1 miRNA could target
many of the same mRNAs that are targeted by a cellular miRNA, as
previously also reported for several other viral miRNAs with seed
homology to cellular miRNAs (Grundhoff and Sullivan, 2011).
While the observed EEHV1 miRNA(s) are unlikely to represent
targets for intervention in EEHV-induced disease, they may have
potential as diagnostics and we were indeed able to readily detect
miR-E3-5p expression in in vivo-derived samples, including whole
blood, by RT-PCR (Table 2). Many EEHV1 infections appear to be
sub-clinical and there is considerable interest in developing
diagnostic tests for EEHV1 to prevent infection of naïve animals
(Hardman et al., 2012; Sariya et al., 2012; Stanton et al., 2010).
In several human diseases, speciﬁc viral or cellular miRNAs are
found at high levels in serum, most likely due to release by cells
inside exosomes (Kuwabara et al., 2011; Tanaka et al., 2013;
Turchinovich et al., 2011; Tzimagiorgis et al., 2011). It is therefore
possible that miR-E3-5p, which is likely expressed at high levels in
EEHV1 infected cells, may also be released into the circulation in
animals that are asymptomatically infected with EEHV1 at levels
that can be detected by RT-PCR. This information, if obtainable,
would allow animal handlers to avoid exposing uninfected ele-
phants to infected, asymptomatic individuals.
Fig. 3. Northern blot detection of miR-E3 expression. 293T cells were transfected
with a miR-E3 expression vector or an empty vector (“-”), and the potential
expression of the pre-miRNA or mature viral miR-E3-5p analyzed by Northern blot.
U6 RNA served as a loading control. White and black arrows show the predicted
location of the miR-E3-5p pre-miRNA and mature miRNA, respectively.
Fig. 4. Inhibitory activity of putative viral miRNAs. An RLuc-based indicator, with or
without two copies of a perfectly complementary target sequence for a putative
EEHV1 miRNA inserted into the 30 UTR, was co-transfected into 293T cells, along
with a putative viral miRNA expression vector, as indicated. Relative RLuc activity
was measured at 48 h post-transfection and then normalized to a vector-only
control and to FLuc, which is present in the same vector and was used here as an
internal control. Error bars indicate standard deviation of 3 independent
experiments.
Table 2
Detection of miR-E3-5p in tissue samples derived from two EEHV1A-infected
elephants using a TaqMan small RNA RT-qPCR assay.
Elephant tissues Threshold cycle (Ct) values
Plus RT enzyme Minus RT enzyme
Raman heart 30.90 No Ct
Raman liver 32.92 No Ct
Raman lung 37.11 No Ct
Raman tongue No Ct No Ct
Raman aorta 39.26 No Ct
Raman blood 37.73 No Ct
Nayan heart 33.97 No Ct
Nayan liver 28.60 No Ct
EEHV-1 negative tissue No Ct No Ct
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Materials and methods
RNA and DNA samples
RNA and DNA were puriﬁed from frozen host cardiac or liver
tissue derived from necropsy specimens of two juvenile Asian
elephants that died as a result of a natural EEHV1A infection. The
heart and liver tissues had 8.1106 and 6.5106 EEHV1A genome
copies per mg of total nucleic acid, respectively.
Small RNA deep sequencing
Total RNA was extracted using TRIzol (Ambion). Small RNAs
were sequentially ligated to adapters and reverse-transcribed
using a TruSeq Small RNA Sample Prep Kit (Illumina) and SSIII
(Invitrogen), as previously described (Umbach and Cullen, 2010)
and the resultant cDNAs ampliﬁed by PCR. The number of PCR
cycles was determined by pilot experiments to ﬁnd a point at
which amplicons showed logarithmic ampliﬁcation. Deep sequen-
cing of the PCR products was performed using an Illumina
HiSeq2500.
Bioinformatics
Sequence data were analyzed using the FASTX-Toolkit and
aligned with the genome of EEHV1A (GenBank accession number:
KC462165) and the African elephant genome (Ensemble accession
number: GCA_000001905) by Bowtie (Langmead et al., 2009).
Results of mapping were analyzed by SAMtools (Li et al., 2009).
RNA secondary structure was predicted by mfold (Zuker, 2003).
TaqMan-based RT-PCR
To extract nucleic acid from elephant tissues for miRNA
RT-qPCR, 25 mg of each tissue was added to a gentleMACS M tube
(Miltenyi Biotec) containing 600 ml of buffer RLT from EZ1 RNA
tissue mini kit (Qiagen). The tissue was homogenized using the
gentleMACS Dissociater (Miltenyi Biotec) and RNA_01 program. The
M tube was then centrifuged at 2000g for 2 min and 350 ml of lysate
was transferred on to the EZ1 XL robot (Qiagen) using the EZ1 RNA
tissue mini kit (Qiagen). Nucleic acid from whole blood was
extracted using the QIAamp Viral RNA Mini Kit (QIAGEN) according
to the manufacturer0s protocol. The miR-E3-5p primers and probe
were designed and synthesized using the Custom TaqMan Small
RNA service (Life Technologies). The RT-qPCR was performed
according to the TaqMan Small RNA Assays protocol using Super-
Script III Reverse Transcriptase (Life Technologies) and QuantiFast
Pathogen PCR þ IC Kit (Qiagen).
Northern blots
Putative mature miRNA sequences, with 240 bp of 50 and 30
ﬂanking sequences, were ampliﬁed by PCR from EEHV1A genomic
DNA, and cloned into the 30 UTR of a gfp gene in the pcDNA3
expression vector. The resultant vectors were transfected into
293T cells using polyethylenimine (Boussif et al., 1995). RNA was
extracted 48 h after transfection and resolved on a 15% denaturing
polyacrylamide gel, transferred to a nylon membrane at 400 mA
for 1 h and then UV crosslinked at 250,000 μJ/cm2. Oligonucleo-
tide probes representing the reverse complement sequence of
putative mature EEHV1 miRNAs were labeled with γ-ATP, hybri-
dized to the nylon membrane using ExpressHyb (Clonetech) and
viewed by autoradiogram.
Luciferase assay
Oligonucleotides bearing two copies of a perfect, full length
target sequence for each putative viral miRNAwere cloned into the
30 UTR of the RLuc gene in psiCHECK2 (Promega). This vector also
includes an FLuc gene, under the control of a different promoter, to
permit normalization of transfection efﬁciency. 293T cells were co-
transfected with an indicator vector and an EEHV1 miRNA expres-
sion vector, as described above, using polyethylenimine. Dual
luciferase assays were performed 24 h after transfection using
a Dual-Luciferase Reporter Assay System (Promega), according to
the manufacturer's protocol.
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